Pro-Dex’s (PDEX) “Buy” Rating Reiterated at Ascendiant Capital Markets
Pro-Dex, Inc. (NASDAQ:PDEX)‘s stock had its “buy” rating reissued by equities researchers at Ascendiant Capital Markets in a research report issued to clients and investors on Friday. They currently have a $9.00 price target on the medical instruments supplier’s stock, up from their prior price target of $8.00. Ascendiant Capital Markets’ target price would suggest a potential upside of 20.00% from the stock’s current price.
Pro-Dex (NASDAQ PDEX) traded up 2.74% during mid-day trading on Friday, reaching $7.50. The company had a trading volume of 43,362 shares. The stock has a 50 day moving average price of $6.46 and a 200-day moving average price of $5.56. The stock has a market capitalization of $30.11 million, a P/E ratio of 6.77 and a beta of -0.42. Pro-Dex has a 12-month low of $3.80 and a 12-month high of $7.55.
Pro-Dex Company Profile
Pro-Dex, Inc (Pro-Dex) designs and produces surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The Company operates through four segments: Pro-Dex, OMS, Fineline and Engineering Services Division (ESD). The Pro-Dex segment provides primarily medical and dental instruments using shared production and assembly machines and workforce.
Receive News & Ratings for Pro-Dex Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex Inc. and related companies with MarketBeat.com's FREE daily email newsletter.